van der Heijde, Désirée <br/><br/>
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.  [electronic resource] 

 -  Lancet (London, England)  12 2019 
 - 2108-2117 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(19)32534-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antirheumatic Agents--therapeutic use<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Heterocyclic Compounds, 3-Ring--therapeutic use<br/>Humans<br/>Hydroxychloroquine--therapeutic use<br/>Janus Kinase Inhibitors--therapeutic use<br/>Magnetic Resonance Imaging<br/>Male<br/>Mesalamine--therapeutic use<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Sacroiliac Joint--diagnostic imaging<br/>Spondylitis, Ankylosing--diagnostic imaging<br/>Sulfasalazine<br/>Treatment Outcome